Intranasal ketamine reduces pain of digital nerve block; a double-blind randomized clinical trial
The American Journal of Emergency Medicine Nov 22, 2018
Nejati A, et al. - Researchers sought the efficacy of IN ketamine in acute pain management in the Emergency Department (ED) via performing a double blind randomized clinical trial on patients older than 15 years who needed digital nerve block (DNB); IN Ketamine (1 ml = 50 mg) or placebo (normal saline, 1 ml) 5 min before DNB was administered to participants randomly. Outcomes suggest a potential efficacy of IN ketamine in reducing pain in patients with acute pain, without adding significant side effects.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries